Lupin has been marketing Ondero and Ondero Met since 2015 in the Indian market as part of a co-marketing agreement with Boehringer Ingelheim and the Indian pharma company acquired the two diabetes brands for Rs 235 crore.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qHsKrd8
via IFTTT
0 comments:
Post a Comment